Form 4: Lilly Endowment Inc. Sells 92,563 Shares of Eli Lilly & Co.

Lilly Endowment Inc. sold 92,563 shares of Eli Lilly & Co. at a weighted average price of $809.211 per share on May 24, 2024.

Summary

• Lilly Endowment Inc., a significant shareholder of Eli Lilly & Co., sold 92,563 shares of common stock.
• The sale occurred on May 24, 2024.
• The shares were sold at a weighted average price of $809.211 per share.
• The price range for the transactions was between $809.00 and $809.90.
• Following the transaction, Lilly Endowment Inc. still beneficially owns 98,556,247 shares of Eli Lilly & Co.

Sentiment

Score: 5

Explanation: The document is a neutral report of a stock sale, with no indication of positive or negative sentiment.

Industry Context

This transaction is a routine disclosure of a significant shareholder's trading activity and does not necessarily indicate a change in the company's outlook or performance.

Comparison to Industry Standards

• Form 4 filings are standard practice for reporting changes in beneficial ownership by insiders and large shareholders in publicly traded companies.
• The sale by Lilly Endowment Inc. is similar to transactions reported by other major shareholders in comparable pharmaceutical companies.
• The volume of shares sold is relatively small compared to the total outstanding shares of Eli Lilly & Co.

Stakeholder Impact

• The sale may have a minor impact on the stock price, but is unlikely to significantly affect other stakeholders.

Key Dates

Keywords

Eli Lilly & Co, Lilly Endowment Inc, stock sale, share transaction, beneficial ownership, LLY